Chikungunya virus in Europe: A retrospective epidemiology study from 2007 to 2023
PLOS Neglected Tropical Diseases · 07.03.2025 · 19 (3) · e0012904
DOI: 10.1371/journal.pntd.0012904 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Neglected Tropical Diseases, online erschienen am 07.03.2025. Verfasst von Qian Liu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory, Beijing Anzhen Hospital, Capital Medical University, Beijing, PR China. Hauptthemen laut MEDLINE: Chikungunya Fever, Chikungunya virus. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Beijing Chao-Yang Hospital Golden Seeds Fundation.
Abstract (Originalsprache)
Background
Chikungunya virus (CHIKV), a mosquito-borne alphavirus, is responsible for disease outbreaks worldwide. However, systematic knowledge of spatiotemporal distribution and risk patterns of CHIKV in mainland Europe remains unclear. Our aim was to decipher the epidemiological characteristics, diversity, and clinical manifestations of CHIKV.
Methods
In this retrospective study, we retrieved the surveillance bulletins of chikungunya infections reported in Europe during 2007–2023 to depict the epidemiological characteristics. We performed genotyping and phylogenetic analyses to examine the evolution and mutation. We also searched PubMed, Web of Science, and Google Scholar to conduct meta-analyses of clinical manifestations.
Results
4730 chikungunya cases across twenty-two countries were documented in mainland Europe from 2007–2022, with no cases reported in 2023. The age-standardized incidence rate was highest in 2014 (0.31), with significant variations observed in each country per year. Although autochthonous outbreaks occurred in several countries, the majority of cases were travel-related, with individuals mainly getting infected during summer vacation. Most travel-related cases were reported as being acquired in India (11.7%), followed by Dominican Republic (9.0%), Guadeloupe (8.7%), and Thailand (7.8%). Genotyping of genome sequences identified two genotypes, with the majority belonging to II-ECSA. The E1 A226V mutation was detected from autochthonous outbreaks, including Italy in 2007 and France in 2014 and 2017. The most common symptoms reported were fever (97.6%), joint pain (94.3%), fatigue (63.5%), and skin rash (52.3%).
Conclusion
The suitable niches for CHIKV are expanding due to climate change and global travel. With the absence of specific antiviral treatments and vaccines still in development, surveillance and vector control are essential in suppressing the re-emergence and epidemics of CHIKV.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Clinical Laboratory, Beijing Anzhen Hospital, Capital Medical University, Beijing, PR China.
- Department of Infectious Diseases and Clinical Microbiology, Beijing Institute of Respiratory Medicine and Beijing Chao-Yang Hospital, Capital Medical University, Beijing, PR China.
ORCID-Profile: Wentao Zhu
Förderung
- Beijing Chao-Yang Hospital Golden Seeds Fundation
Zitieren
APA
Liu, Q., Shen, H., Gu, L., Yuan, H., & Zhu, W. (2025). Chikungunya virus in Europe: A retrospective epidemiology study from 2007 to 2023. PLOS Neglected Tropical Diseases, 19(3), e0012904. https://doi.org/10.1371/journal.pntd.0012904
Vancouver
Liu Q, Shen H, Gu L, Yuan H, Zhu W. Chikungunya virus in Europe: A retrospective epidemiology study from 2007 to 2023. PLOS Neglected Tropical Diseases. 2025;19(3):e0012904. doi:10.1371/journal.pntd.0012904
BibTeX
@article{Liu2025,
author = {Liu, Qian and Shen, Hong and Gu, Li and Yuan, Hui and Zhu, Wentao},
title = {Chikungunya virus in Europe: A retrospective epidemiology study from 2007 to 2023},
journal = {PLOS Neglected Tropical Diseases},
year = {2025},
volume = {19},
number = {3},
pages = {e0012904},
doi = {10.1371/journal.pntd.0012904}
}
EUVIMED